Previous 10 | Next 10 |
Image source: The Motley Fool. Invitae Corp (NYSE: NVTA) Q3 2019 Earnings Call Nov 6, 2019 , 4:30 p.m. ET Operator Continue reading
Invitae (NYSE: NVTA ) is scheduled to announce Q3 earnings results on Wednesday, November 6th, after market close. The consensus EPS Estimate is -$0.58 (-28.9% Y/Y) and the consensus Revenue Estimate is $54.85M (+46.7% Y/Y). Over the last 2 years, nvta has beaten EPS estimates 38% of...
SALT LAKE CITY , Nov. 5, 2019 /PRNewswire/ -- Researchers from Invitae Corporation (NYSE: NVTA), a leading medical genetics company, are presenting research this week at the National Society of Genetic Counselors (NSGC) 37th Annual Conference in Atlanta that helps push for...
Editor's note: Seeking Alpha is proud to welcome Kerhan Woo as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA PREMIUM. Click here to find out more » As a professional in t...
Below are the five companies in the Biotechnology industry with the lowest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry. Actinium Pharmaceuticals Inc. ranks lowest with sales per share of $0.00. Following is Pfenex Inc. w...
SAN FRANCISCO , Oct. 23, 2019 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its third quarter 2019 financial results on Wednesday, November 6, 2019 and will host a conference call and webcast that day at ...
Below are the five companies in the Biotechnology industry with the highest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry. AbbVie Inc. ranks highest with sales per share of $18.55. Emergent BioSolutions Inc. is next with s...
We published our recent bearish thesis on Invitae (NVTA) knowing it was going to ruffle some feathers. Amazon references, a large retail ownership, and media vocal shareholders ensured that. However, we were disappointed to see our work labeled as a short-seller attack. We are long/short inv...
HOUSTON , Oct. 17, 2019 /PRNewswire/ -- Researchers from Invitae Corporation (NYSE: NVTA), a leading medical genetics company, are presenting data showing the increasing utility of genetic information at the American Society of Human Genetics (ASHG) annual meeting this week, rang...
“We have been living and illusion that revenue and growth equals success. Even the press goes for it” -Bill Gurley 1) Invitae: The Amazon of Genetics? Invitae’s social mission is to provide affordable genetic testing for all. This has somehow earned the...
News, Short Squeeze, Breakout and More Instantly...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance PR Newswire – Study findings to be presented at the 2024 American Society of Breast Surgeons Annual Meeting – SAN FRANCISCO , April 11, 2024 /PRNewsw...